← Insider Monitor
BIOMARIN PHARMACEUTICAL INC logo
BMRN

BIOMARIN PHARMACEUTICAL INC

Nasdaq · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

BioMarin Pharmaceutical develops and sells treatments for rare genetic diseases, including enzyme replacement therapies for conditions like Hunter syndrome, Morquio A syndrome, and PKU, as well as a gene therapy for hemophilia A.

Industry
Pharmaceutical Preparations
Headquarters
Novato, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Friberg Gregory REVP, Chief R&D OfficerSell$303KNov 18, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for BMRN.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable BMRN activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.